ArticleMedical cannabis and cannabinoids
Factors Associated with Possible Cannabis Use Disorder among Adults Using Medical Cannabis in Florida: A Cross-Sectional Study.
Article in Medical cannabis and cannabinoids. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The number of people using medical cannabis has increased in the United States, but little is known about the prevalence or risk factors for Cannabis Use Disorder (CUD) in this population. We sought to estimate the prevalence of CUD and to identify individual characteristics and cannabis use patterns associated with CUD in a statewide sample of adults certified to use medical cannabis. Methods: The sample included 632 adults (median age 45, 63% female, 75% non-Hispanic White) certified and currently using medical cannabis in Florida. Participants were recruited from medical cannabis clinics and completed an online cross-sectional survey in 2022. The primary outcome, based on the 8-item Cannabis Use Disorder Identification Test-Revised (CUDIT-R), was categorized as possible CUD (CUDIT-R score ≥12), hazardous use (score ≥8), or non-hazardous use (<8). Independent variables included sociodemographics; mental health diagnoses; past-5-year substance use; cannabis use history, motives, and patterns; and concern about addiction or dependence. Bivariate analyses and multivariable logistic regression examined associations with possible CUD, with secondary analysis examining associations with any hazardous use. Results: Overall, 20% (95% CI: 17%-24%) had possible CUD) and 54% (95% CI: 50%-58%) had hazardous use. Possible CUD was significantly associated with younger age (aOR 0.98, 95% CI: 0.96-1.0), >1 year of daily marijuana use (1-5 years aOR 2.2 95% CI: 1.2-5.2; 6+ years aOR 3.1 95% CI: 1.5-7.2), lower preference for oral concentrates (aOR 0.29, 95% CI: 0.10-0.70), and self-reported recreational reasons for marijuana use (aOR 5.1, 95% 1.5-17.3). Possible CUD was not associated with sex, race/ethnicity, mental health conditions, or preferred THC percentage. Hazardous use was associated with >1 year of daily marijuana use, recreational reasons for use, younger age at marijuana use, greater preference for marijuana flower, and anxiety diagnosis. Few (4%) reported concern about addiction of dependence. Discussion: About 1 in 5 adults certified to use medical cannabis in Florida had possible CUD, and over half (54%) had hazardous use. Possible CUD was associated with younger age, prolonged daily use, lower preference for oral concentrates, and recreational motives for marijuana use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.